BRPI0516303A - método de produção de colágeno em planta ou em célula de planta isolada, planta geneticamente modificada ou célula de planta isolada, sistema de planta, método de produção de colágeno fibirilar e construção de ácido nucléico - Google Patents

método de produção de colágeno em planta ou em célula de planta isolada, planta geneticamente modificada ou célula de planta isolada, sistema de planta, método de produção de colágeno fibirilar e construção de ácido nucléico

Info

Publication number
BRPI0516303A
BRPI0516303A BRPI0516303-0A BRPI0516303A BRPI0516303A BR PI0516303 A BRPI0516303 A BR PI0516303A BR PI0516303 A BRPI0516303 A BR PI0516303A BR PI0516303 A BRPI0516303 A BR PI0516303A
Authority
BR
Brazil
Prior art keywords
plant
production method
collagen production
isolated
plant cell
Prior art date
Application number
BRPI0516303-0A
Other languages
English (en)
Inventor
Hanan Stein
Oded Shoseyov
Original Assignee
Collplant Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35788568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0516303(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Collplant Ltd filed Critical Collplant Ltd
Publication of BRPI0516303A publication Critical patent/BRPI0516303A/pt
Publication of BRPI0516303B1 publication Critical patent/BRPI0516303B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8273—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C12Y114/11002—Procollagen-proline dioxygenase (1.14.11.2), i.e. proline-hydroxylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C12Y114/11004—Procollagen-lysine 5-dioxygenase (1.14.11.4), i.e. lysine-hydroxylase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fertilizers (AREA)
  • Cosmetics (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

MéTODO DE PRODUçãO DE COLáGENO EM PLANTA OU EM CéLULA DE PLANTA ISOLADA, PLANTA GENETICANENTE MODIFICADA OU CéLULA DE PLANTA ISOLADA, SISTEMA DE PLANTA, MéTODO DE PRODUçãO DE COLáGENO FIBIRILAR E CONSTRUçãO DE áCIDO NUCLéICO. Compreende um método para produzir colágeno em uma planta e plantas para produzir colágeno são estabelecidos; o método é efetuado exprimindo na planta pelo menos um tipo de colágeno da cadeia alfa de maneira a permitir a acumulação de colágeno da cadeia alfa em um compartimento subcelular livre de atividade endógena P4H, por meio disso produzindo o colágeno na planta.
BRPI0516303-0A 2004-09-29 2005-09-28 Método de produção de colágeno em planta ou em célula de planta isolada BRPI0516303B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61371904P 2004-09-29 2004-09-29
US60/613,719 2004-09-29
PCT/IL2005/001045 WO2006035442A2 (en) 2004-09-29 2005-09-28 Collagen producing plants and methods of generating and using same

Publications (2)

Publication Number Publication Date
BRPI0516303A true BRPI0516303A (pt) 2008-09-02
BRPI0516303B1 BRPI0516303B1 (pt) 2021-04-13

Family

ID=35788568

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0516303-0A BRPI0516303B1 (pt) 2004-09-29 2005-09-28 Método de produção de colágeno em planta ou em célula de planta isolada

Country Status (15)

Country Link
US (4) US8455717B2 (pt)
EP (6) EP3312282B1 (pt)
JP (2) JP5100386B2 (pt)
KR (1) KR20070083870A (pt)
CN (1) CN101065491B (pt)
AT (1) ATE479762T1 (pt)
BR (1) BRPI0516303B1 (pt)
CA (1) CA2582051C (pt)
DE (1) DE602005023332D1 (pt)
HK (1) HK1251611B (pt)
IL (1) IL182320A (pt)
MX (1) MX2007003767A (pt)
NZ (1) NZ554787A (pt)
WO (1) WO2006035442A2 (pt)
ZA (1) ZA200703369B (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7378506B2 (en) 1997-07-21 2008-05-27 Ohio University Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
US6639050B1 (en) 1997-07-21 2003-10-28 Ohio University Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
MXPA06008126A (es) 2004-01-14 2008-02-14 Univ Ohio Metodos para la produccion de peptidos/proteinas en plantas y peptidos/proteinas producidos de este modo.
US8623812B2 (en) 2004-04-19 2014-01-07 Ohio University Cross-linkable glycoproteins and methods of making the same
DE602005023332D1 (de) 2004-09-29 2010-10-14 Collplant Ltd Kollagenproduzierende pflanzen sowie verfahren zu deren erzeugung und verwendung
EP2084285A4 (en) * 2006-07-10 2010-01-13 Univ Ohio COEXPRESSION OF PROLIN HYDROXYLASES TO FACILITATE HYP-GLYCOSYLATION OF PROTEINS EXPRESSED AND SEPARATED IN PLANT CELLS
WO2009053985A1 (en) * 2007-10-26 2009-04-30 Collplant Ltd. Methods of processing recombinant procollagen
JP2011504374A (ja) 2007-11-26 2011-02-10 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド 繊維状ポリペプチドおよび多糖を含む組成物
US9095569B2 (en) * 2008-04-18 2015-08-04 Collplant Ltd. Methods of generating and using procollagen
EP2504472A1 (en) 2009-11-24 2012-10-03 Collplant Ltd. Method of generating collagen fibers
WO2012066543A2 (en) 2010-11-16 2012-05-24 Collplant Ltd. Collagen structures and method of fabricating the same
EP2751132B1 (en) 2011-09-01 2022-11-30 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Adhesive biopolymers and uses thereof
WO2013093921A1 (en) 2011-12-20 2013-06-27 Collplant Ltd. Collagen coated synthetic polymer fibers
KR102063686B1 (ko) * 2012-01-02 2020-02-11 (주)아모레퍼시픽 콩뿌리 추출물을 함유하는 피부 외용제 조성물
ES2883580T3 (es) 2013-03-21 2021-12-09 Collplant Ltd Composiciones que comprenden colágeno y PRP para la regeneración de tejidos y su método de producción
WO2014146175A1 (en) 2013-03-21 2014-09-25 Commonwealth Scientific And Industrial Research Organisation Purification of triple helical proteins
GB201308120D0 (en) * 2013-05-06 2013-06-12 Baden Wuerttemberg Stiftung Gmbh Recombinant protein and method for its production
CN105764920B (zh) 2013-09-09 2020-07-24 联邦科学工业研究组织 修饰的细菌胶原蛋白样蛋白
WO2016079739A2 (en) 2014-11-20 2016-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
CN104630227A (zh) * 2015-02-09 2015-05-20 安徽农业大学 一种草莓镶脉病毒的组成型表达启动子
WO2017196742A1 (en) 2016-05-09 2017-11-16 Bioventus, Llc Composite matrices designed for enhanced bone repair
CA3065481A1 (en) 2017-06-09 2018-12-13 Collplant Ltd. Additive manufacturing using recombinant collagen-containing formulation
US20210032311A1 (en) * 2017-09-25 2021-02-04 Yu-Chun Wu Non-human gene-edited mammal, protein crude extract separated from connective tissue of non-human gene-edited mammal, method for protein crude extract and uses of protein crude extract
EP3787702B1 (en) 2018-05-03 2024-08-07 CollPlant Ltd. Dermal fillers and applications thereof
FR3082726A1 (fr) * 2018-06-24 2019-12-27 Michel Assor Implant méniscal : composite en polyuréthane et autres polymères, avec collagène humain recombinant de plante, biodégradable et colonisable, dans l’arthrose évoluée du genou
AU2019315054A1 (en) * 2018-07-31 2021-03-18 Collplant Ltd. Tobacco transgenic event and methods for detection and use thereof
CN109988234A (zh) * 2019-02-20 2019-07-09 江苏悦智生物医药有限公司 酵母重组人源I型胶原α1链蛋白、合成方法及其应用
EP3789048B1 (fr) * 2019-09-03 2023-06-07 Michel Assor Scaffold méniscal composite comprenant du collagène humain recombinant
JP2023501625A (ja) * 2019-11-11 2023-01-18 エフゲニエヴィチ カムチャロフ、アレクサンドル コラーゲンおよび追加の添加剤入り飲料
FR3105792B1 (fr) 2019-12-26 2022-08-12 Michel Assor Matériau biocomposite collagène/matrice polymérique poreuse et son utilisation comme implant de réparation de lésions méniscales du genou et/ou de prévention ou de traitement de l’arthrose du genou
CN115003803A (zh) * 2020-02-14 2022-09-02 现代牧场股份有限公司 用于羟基化氨基酸的单体蛋白质和产品
EP3872182A1 (en) * 2020-02-28 2021-09-01 Alganelle Recombinant microalgae able to produce peptides, polypeptides or proteins of collagen, elastin and their derivatives in the chloroplast of microalgae and associated method thereof
WO2021229577A1 (en) 2020-05-12 2021-11-18 Collplant Ltd. Collagen as a delivery tool for metal-based anti-viral agents
WO2023194333A1 (en) 2022-04-04 2023-10-12 Swiftpharma Bv Recombinant spider silk-reinforced collagen proteins produced in plants and the use thereof
EP4567113A1 (en) * 2022-08-02 2025-06-11 Unibio Corporation Collagen production method
CN117209592A (zh) * 2023-07-26 2023-12-12 浙江大学 一种人源化i型胶原蛋白及其制备方法与应用
CN118813566B (zh) * 2024-07-31 2025-05-27 东莞恒医生物科技有限公司 一种BaP4H突变体及其制备方法和应用
WO2026062644A1 (en) 2024-09-20 2026-03-26 Collplant Ltd. Light-absorbing substances suitable for use in additive manufacturing and methods of identification thereof
CN121717897A (zh) * 2026-02-26 2026-03-24 北京齐禾生科生物科技有限公司 一种在大豆中表达i型胶原蛋白的多基因表达盒及方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
CA1192510A (en) 1981-05-27 1985-08-27 Lawrence E. Pelcher Rna plant virus vector or portion thereof, a method of construction thereof, and a method of producing a gene derived product therefrom
JPS6054684A (ja) 1983-09-05 1985-03-29 Teijin Ltd 新規ｄνａ及びハイブリツドｄνａ
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
CA1288073C (en) 1985-03-07 1991-08-27 Paul G. Ahlquist Rna transformation vector
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
GB8608850D0 (en) 1986-04-11 1986-05-14 Diatech Ltd Packaging system
JPS6314693A (ja) 1986-07-04 1988-01-21 Sumitomo Chem Co Ltd 植物ウイルスｒｎａベクタ−
DE3850683T2 (de) 1987-02-09 1994-10-27 Lubrizol Genetics Inc Hybrides RNS-Virus.
US5316931A (en) 1988-02-26 1994-05-31 Biosource Genetics Corp. Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes
US5693507A (en) 1988-09-26 1997-12-02 Auburn University Genetic engineering of plant chloroplasts
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5593859A (en) * 1991-10-23 1997-01-14 Thomas Jefferson University Synthesis of human procollagens and collagens in recombinant DNA systems
US20020142391A1 (en) 1991-06-12 2002-10-03 Kivirikko Kari I. Synthesis of human procollagens and collagens in recombinant DNA systems
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US20020098578A1 (en) 1992-10-22 2002-07-25 Darwin J. Prockop Synthesis of human procollagens and collagens in recombinant dna systems
US6713662B1 (en) 1994-07-27 2004-03-30 Pharming Intellectual Property B.V. Production of collagen in the milk of transgenic mammals
WO1997004123A1 (en) 1995-07-19 1997-02-06 Gel Tech Group Inc. Collagen compound production in plants
WO1997038710A1 (en) 1996-04-12 1997-10-23 Fibrogen, Inc. Synthesis of human procollagens and collagens in recombinant dna systems
FR2757874B1 (fr) * 1996-12-17 2003-04-25 Biocem Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2001518305A (ja) 1997-09-30 2001-10-16 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 植物種子におけるタンパク質製造
BR9915919A (pt) 1998-10-07 2001-08-21 Syngenta Participations Ag Proteìnas terapeuticamente ativas em plantas
BR0014945A (pt) * 1999-10-21 2004-08-31 Monsanto Co Modificação pós-traducional de proteìnas recombinantes produzidas em plantas
CN1285612C (zh) * 1999-11-12 2006-11-22 法布罗根股份有限公司 动物胶原和明胶
EP1232182B1 (en) * 1999-11-12 2007-10-03 Fibrogen, Inc. Bovine collagen and method for producing recombinant gelatin
US20030033637A1 (en) * 2001-06-05 2003-02-13 Croptech Corporation Gene expression and production of TGF-beta proteins including bioactive mullerian inhibiting substance from plants
JP4426307B2 (ja) * 2002-02-08 2010-03-03 ノボザイムス アクティーゼルスカブ フィターゼ変異体
CA2510462A1 (en) * 2002-12-19 2004-07-08 University Of Bristol Method for producing polyunsaturated fatty acids in a transgenic plant or microorganism comprising an introduced delta-9-elongase and a delta-8-desaturase
US20060058190A1 (en) * 2002-12-20 2006-03-16 Thomas Ehrhardt Malate dehydrogenase as a target for herbicides
US20050059053A1 (en) 2003-07-21 2005-03-17 Rainer Fischer Complex formation for the stabilisation and purification of proteins of interest
DE602005023332D1 (de) 2004-09-29 2010-10-14 Collplant Ltd Kollagenproduzierende pflanzen sowie verfahren zu deren erzeugung und verwendung

Also Published As

Publication number Publication date
US8455717B2 (en) 2013-06-04
BRPI0516303B1 (pt) 2021-04-13
EP2816117A3 (en) 2015-05-27
IL182320A (en) 2015-06-30
ZA200703369B (en) 2008-08-27
CN101065491A (zh) 2007-10-31
HK1114405A1 (zh) 2008-10-31
HK1160176A1 (en) 2012-08-10
EP1809751B1 (en) 2010-09-01
ATE479762T1 (de) 2010-09-15
EP2816117B1 (en) 2016-11-30
US9783816B2 (en) 2017-10-10
MX2007003767A (es) 2007-07-17
EP3312282B1 (en) 2019-07-03
US20070186312A1 (en) 2007-08-09
US20180044692A1 (en) 2018-02-15
EP3312282A1 (en) 2018-04-25
HK1251611B (en) 2020-06-19
EP1809751A2 (en) 2007-07-25
EP2816117A2 (en) 2014-12-24
DE602005023332D1 (de) 2010-10-14
EP3088528B1 (en) 2019-07-03
CA2582051C (en) 2015-08-11
JP2008514225A (ja) 2008-05-08
JP2012085644A (ja) 2012-05-10
EP3088528A1 (en) 2016-11-02
IL182320A0 (en) 2007-07-24
EP2357241B1 (en) 2015-03-04
US20120284817A1 (en) 2012-11-08
EP2360261A1 (en) 2011-08-24
WO2006035442A3 (en) 2006-05-04
JP5100386B2 (ja) 2012-12-19
JP5517309B2 (ja) 2014-06-11
US10626408B2 (en) 2020-04-21
US20130289243A1 (en) 2013-10-31
KR20070083870A (ko) 2007-08-24
CN101065491B (zh) 2012-01-11
NZ554787A (en) 2009-05-31
EP2357241A1 (en) 2011-08-17
CA2582051A1 (en) 2006-04-06
WO2006035442A2 (en) 2006-04-06
WO2006035442A8 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
BRPI0516303A (pt) método de produção de colágeno em planta ou em célula de planta isolada, planta geneticamente modificada ou célula de planta isolada, sistema de planta, método de produção de colágeno fibirilar e construção de ácido nucléico
AR051527A1 (es) Planta transformada que expresa una dextranosucrasa y sintetiza un almidon modificado
AR050299A1 (es) Plantas con una enzima fosforilante del almidon con una actividad aumentada en plástidos.
AR046090A1 (es) Plantas con actividad aumentada de una enzima de ramificacion de la clase 3
CL2012001145A1 (es) Método para liberar un polisacárido capsular a partir de células tipo 5 o tipo 8 de staphilococcus aureus, que comprende la etapa de tratar las células con un ácido; proceso para purificar dicho polisacárido; composición que comprende estos polisacáridos.
BRPI0409363A (pt) métodos e meios para o aumento da toleráncia de plantas a condições de tensão
AR056256A1 (es) Plantas resistentes al estres
AR062301A1 (es) Plantas modificadas geneticamente que sintetizan un almidon con mayor capacidad de hinchamiento
BR112012033699A2 (pt) polipeptídeo tendo atividade beta-glicosidase e seus usos
AR046089A1 (es) Plantas con actividad restringida de una enzima de ramificacion de la clase 3
BRPI0411182A (pt) método para aumentar a toleráncia de uma planta ao estresse abiótico, método para aumentar a biomassa de uma planta, construto de ácido nucléico, polipeptìdio isolado e célula de planta
BR0011499A (pt) Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado
AR075545A1 (es) Plantas con caracteristicas modificadas de crecimiento y un metodo para obtenerlas
BR112012033703A2 (pt) polipeptídeo tendo atividade beta-glicosidase e seus usos
BR112012033404A2 (pt) polipetídeo tendo ou auxiliando a atividade de degradação de material de carboidratos e uso dos mesmos.
CL2008001761A1 (es) Polinucleotidos que codifican proteinas que modifican el desarrollo de la pared celular secundaria en plantas, casete de expresion y celula huesped que las comprenden, y metodo para modular l desarrollo e una planta completa o de la pared celular de la misma.
BR0307253A (pt) Construtos de dna, sistema de expressão, métodos de supressão da expressão de um gene alvo numa célula, célula de planta transformada, planta transgênica e kit de supressão de expressão genética
AR060435A1 (es) Polipeptidos relacionados con esteres y metodos para su uso en plantas
BRPI0907089A2 (pt) métodos para aumentar características relacionadas ao rendimento com relação a plantas de controle e para a produção de plantas transgênicas, plantas, partes de plantas ou células de planta, construto, uso de um construto, partes colhíveis, produtos, e, uso de uma sequência de ácido nucléico.
CL2011002093A1 (es) Construcciones que comprenden un promotor especifico de senenscencia unido a una secuencia codificante para un polipéptido con actividad piruvato ortofosfato diquinasa (ppdk) citosólica, vector, célula y método para producir una planta que re-moviliza nitrógeno.
CL2008003469A1 (es) Acido nucleico aislado de maiz asociado con la senalizacion de etileno en plantas; casete de expresion; celula huesped; proteina codificada; y metodo de modulacion de la respuesta de etileno en una planta.
BRPI0606363A2 (pt) método para o isolamento e/ou a purificação de ácidos nucleicos ácido nucleico, e, método para a imobilização de ácidos nucleicos em uma matriz
BR112017010555A2 (pt) composições e métodos para produção de polipeptídeos com padrão de glicosilação modificado em células vegetais
BR0309860A (pt) plantas transgênicas com elevado teor de triptofano
BR112012033701A2 (pt) polipeptídeo tendo atividade de degradação de carbohidrato e seus usos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/04/2021, OBSERVADAS AS CONDICOES LEGAIS.